HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2022-07-01Clinical Trial Update: Healing Hearts and Mending Minds in Older Adults Living With HIV [NA]
A completed clinical trial funded by Emory University studying HIV and cardiovascular disease in older adults; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-24Clinical Trial Update: Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women [NA]
Completed clinical trial evaluating a computerized brief alcohol intervention for women at risk of or living with HIV; results posted in 202…
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c) [Phase 4]
Phase 4 trial evaluating reversibility of CNS-related neurotoxicity after switching to a darunavir/cobicistat-based regimen in people with H…
-
CLINICAL_TRIALS trial_result · 2022-06-10Clinical Trial Update: Switch to TAF+FTC+BIC in HIV-1-infected Patients Over 65 Years Old at Risk of Polymedication [Phase 4]
Phase 4 clinical trial examining switching to TAF+FTC+BIC in HIV-1-infected patients over 65 at risk of polypharmacy.
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: ADORE: Efficacy of DORavirine in Adults Living With HIV Experiencing Virological Failure on First-line Efavirenz-based Antiretroviral Therapy With NNRTI Resistance [Phase 3]
Phase 3 trial evaluating DORavirine in adults with HIV experiencing virological failure on first-line efavirenz-based ART with NNRTI resista…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Doravirine Concentrations and Antiviral Activity in Genital Fluids in HIV-1 Infected Individuals [Phase 2]
Phase 2 trial update evaluating doravirine concentrations and antiviral activity in genital fluids from HIV-1 infected individuals.
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients [Phase 2]
A Phase 2 clinical trial update evaluating UB-421 for functional cure potential in ART-stabilized HIV-1 patients.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients [Phase 2]
Phase 2 trial update assessing the HIV functional cure potential of UB-421 in ART-stabilized HIV-1 patients has completed.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: The BRIgHT Program: Building Resilience in HIV Together [NA]
A completed clinical trial (BRIgHT Program) evaluating resilience in HIV-related psychological conditions; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-13Clinical Trial Update: Open Label Extension (OLE) of the TDF2 Study, Botswana [NA]
Open-label extension update for the TDF2 study conducted in Botswana, completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants [Phase 1]
This Phase 1 trial update evaluates the safety and immunogenicity of an HIV-1 gp41 MPER-656 liposome vaccine in healthy, HIV-uninfected adul…
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals [Phase 3]
A Phase 3 trial update reports on doravirine concentrations and antiviral activity in cerebrospinal fluid of HIV-1 infected individuals.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up [Phase 2, Phase 3]
Phase 2/Phase 3 trial update comparing treatments for HIV-infected opioid users within an integrated care model (CHOICES) completed with res…
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Islatravir (MK-8591) With Doravirine and Lamivudine in Participants Infected With Human Immunodeficiency Virus Type 1 (MK-8591-011) [Phase 2]
Phase 2 trial update for islatravir with doravirine and lamivudine in HIV-1 infection completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-04-25Clinical Trial Update: Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan Africa [NA]
A completed clinical trial evaluating resistance testing to improve management of virologic failure in HIV/AIDS patients in Sub-Saharan Afri…
-
CLINICAL_TRIALS trial_result · 2022-04-19Clinical Trial Update: HIV Non-Occupational Post-Exposure Prophylaxis [Phase 4]
Phase 4 clinical trial update on non-occupational post-exposure prophylaxis for HIV has completed with results posted.
-
FDA approval · 2022-04-14FDA Approved: PREZCOBIX — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for PrezcoBix (darunavir ethanolate and cobicistat) from Janssen Products, LP.
-
FDA approval · 2022-04-14FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP.
-
FDA label_change · 2022-04-14FDA Approved: SYMTUZA — Supplemental Application (Janssen Products LP)
FDA approved Janssen's supplemental application for SYMTUZA, updating its labeling for the fixed-dose combination of darunavir, cobicistat, …
-
FDA approval · 2022-04-13FDA Approved: ETRAVIRINE — Original Application (Carnegie Pharmaceuticals LLC)
The FDA approved Carnegie Pharmaceuticals LLC's original-application for etravirine, allowing a generic version of the HIV-1 non-nucleoside …
-
CLINICAL_TRIALS withdrawal · 2022-04-12Clinical Trial Update: Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study [Phase 4]
A Phase 4 pilot trial evaluating dolutegravir-lamivudine dual therapy in ART-naïve HIV-1 patients with M184V mutation has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: High-Dose Vitamin D3 Supplementation in the Treatment of Human Immune Deficiency Virus Patients Trial [Phase 3]
Phase 3 trial evaluating high-dose vitamin D3 supplementation in HIV-1 infection patients with vitamin D deficiency has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-08Clinical Trial Update: Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection [Phase 3]
Phase 3 trial assessing safety and efficacy of triptolide wilfordii in new onset HIV-1 infection has completed.
-
CLINICAL_TRIALS trial_result · 2022-04-07Clinical Trial Update: Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP) [Phase 4]
Phase 4 trial update for Biktarvy used as non-occupational post-exposure prophylaxis (nPEP) in HIV prevention; study completed.
-
FDA approval · 2022-04-06FDA Approved: ABACAVIR, LAMIVUDINE AND ZIDOVUDINE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for a generic fixed-dose combination of abacavir, lamivudine, and zidovudin…